{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:05:29Z","timestamp":1790622329928,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,12,1]],"date-time":"2000-12-01T00:00:00Z","timestamp":975628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatr Q"],"published-print":{"date-parts":[[2000,12]]},"DOI":"10.1023\/a:1004640408501","type":"journal-article","created":{"date-parts":[[2002,12,21]],"date-time":"2002-12-21T14:00:06Z","timestamp":1040479206000},"page":"373-384","source":"Crossref","is-referenced-by-count":111,"title":["Treatment Refractory Schizophrenia"],"prefix":"10.1007","volume":"71","author":[{"given":"Jean-Pierre","family":"Lindenmayer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"226391_CR1","unstructured":"Beuzen J-N, Birkett MA, Kiesler GM, Tollefson GD, Wood AJ, Beasley CW (1998): Olanzapine vs. clozapine: an international double-blind study in the treatment of resistant schizophrenia. 37th ACNP Annual Meeting, December 14-18, 1998, Puerto Rico (Abstract)."},{"key":"226391_CR2","unstructured":"Birkett M, Dossenbach M, Shoshani D, Tran P and Rampey V (1996): Treatment failure with clozapine: can olanzapine be the alternative therapy? 35th Annual Meeting of the American College of Neuropsychopharmacology, December 9-13: 253 (Abstract)."},{"key":"226391_CR3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1176\/ajp.155.4.499","volume":"155","author":"G Bondolfi","year":"1998","unstructured":"Bondolfi G, Dufour H, Patris M, et al.: Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. Am J Psychiatry. 155:499\u2013504, 1998.","journal-title":"Am J Psychiatry"},{"key":"226391_CR4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0006-3223(98)00291-1","volume":"45","author":"A Breier","year":"1999","unstructured":"Breier A, Hamilton SH. Comparative efficacy of olanzapine and haloperidol for patients with treatment-resistant schizophrenia. Biol Psychiatry 45:403\u2013411, 1999.","journal-title":"Biol Psychiatry"},{"key":"226391_CR5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1176\/ajp.151.1.20","volume":"151","author":"A Breier","year":"1994","unstructured":"Breier A, Buchanan RW, Kirkpatrick B, et al.: Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. Am J Psychiatry 151:20\u201326, 1994.","journal-title":"Am J Psychiatry"},{"key":"226391_CR6","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/schbul\/23.4.663","volume":"23","author":"RR Conley","year":"1997","unstructured":"Conley RR, Buchanan RW: Evaluation of treatment-resistant schizophrenia. Schizophr Bull. 23:663\u2013674, 1997.","journal-title":"Schizophr Bull."},{"key":"226391_CR7","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1176\/ajp.155.7.914","volume":"155","author":"RR Conley","year":"1998","unstructured":"Conley RR, Tamminga CA, Bartko JJ, et al.: Olanzapine compared with chlorpromazine in treatment resistant schizophrenia. Am J Psychiatry 155: 914\u2013920, 1998.","journal-title":"Am J Psychiatry"},{"key":"226391_CR8","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1192\/bjp.148.2.120","volume":"148","author":"TJ Crow","year":"1986","unstructured":"Crow TJ et al.: Br J Psychiatry 148:120\u2013127, 1986.","journal-title":"Br J Psychiatry"},{"key":"226391_CR9","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/schbul\/6.1.70","volume":"6","author":"JM Davis","year":"1980","unstructured":"Davis JM, Schaffer CB, Killian GA, Kinard C, Chan C: Important issues in the drug treatment of schizophrenia. Schizophr Bull 6:70\u201387, 1980.","journal-title":"Schizophr Bull"},{"issue":"suppl23","key":"226391_CR10","first-page":"10","volume":"60","author":"R Emsley","year":"1999","unstructured":"Emsley R: Partial Response to Antipsychotic Treatment: The Patient with Enduring Symptoms. J. of Clin Psychiatry 60(suppl 23):10\u201313, 1999.","journal-title":"J. of Clin Psychiatry"},{"key":"226391_CR11","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/schbul\/6.4.592","volume":"6","author":"G Huber","year":"1980","unstructured":"Huber G et al.: Longitudinal studies of schizophrenic patients. Schizophr Bull 6:592\u2013605, 1980.","journal-title":"Schizophr Bull"},{"key":"226391_CR12","first-page":"1103","volume-title":"Psychopharmacology: The Third Generation of Progress","author":"JA Kane","year":"1987","unstructured":"Kane JA, Lieberman JA: Maintenance pharmacotherapy in schizophrenia. In: Meltzer HY, ed. Psychopharmacology: The Third Generation of Progress. New York, NY: Raven Press 1103\u20131109, 1987."},{"key":"226391_CR13","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","volume":"45","author":"J Kane","year":"1998","unstructured":"Kane J, Honigfeld G, Singer J, Meltzer H, Group at CCS: Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 45:789\u2013796, 1998.","journal-title":"Arch Gen Psychiatry"},{"key":"226391_CR14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-3223(90)90650-Q","volume":"27","author":"MJ Kaplan","year":"1990","unstructured":"Kaplan MJ, Lazoff M, Kelly K, Lukin R, Garver DL: Enlargement of cerebral third ventricle in psychotic patients with delayed response to neuroleptics. Biol Psychiatry 27:205\u2013214, 1990.","journal-title":"Biol Psychiatry"},{"issue":"suppl22","key":"226391_CR15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1192\/S0007125000292544","volume":"163","author":"JA Lieberman","year":"1993","unstructured":"Lieberman JA: Understanding the mechanism of action of atypical antipsychotic drugs. A review of compounds in use and development [published erratum appears in Br J Psychiatry 1994; 164:709]. Br J Psychiatry. 163(suppl 22):7\u201318, 1993.","journal-title":"Br J Psychiatry"},{"key":"226391_CR16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archpsyc.1993.01820170047006","volume":"50","author":"J Lieberman","year":"1993","unstructured":"Lieberman J, Jody D, Geisler S, et al.: Time course and biologic correlates of 384 PSYCHIATRIC QUARTERLY treatment response in first-episode schizophrenia. Arch Gen Psychiatry 50:369\u2013376, 1993.","journal-title":"Arch Gen Psychiatry"},{"key":"226391_CR17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archpsyc.1993.01820170047006","volume":"50","author":"J Lieberman","year":"1993","unstructured":"Lieberman J et al.: Time course and biologic correlates of treatment response in first-episode schizophrenia. Arch Gen Psychiatry 50:369\u2013376, 1993.","journal-title":"Arch Gen Psychiatry"},{"issue":"suppl9","key":"226391_CR18","first-page":"5","volume":"57","author":"JA Lieberman","year":"1996","unstructured":"Lieberman JA et al.: Factors influencing treatment response and outcome of first-episode schizophrenia. J Clin Psychiatry. 57(suppl 9):5\u20139, 1996.","journal-title":"J Clin Psychiatry"},{"issue":"suppl9","key":"226391_CR19","first-page":"5","volume":"57","author":"JA Lieberman","year":"1996","unstructured":"Lieberman JA, Koreen AR, Chakos M et al.: Factors influencing treatment response an doutcome of first-episode schizohrenia: implications for understanding the pathophysiology of schizophrenia. J Clin Psychiatry 57(suppl 9): 5\u20139, 1996.","journal-title":"J Clin Psychiatry"},{"key":"226391_CR20","unstructured":"Lindenmayer JP, Volavka J, Lieberman J, Sheitman B, Chakos M, Czobor P, Parker BJ, Iskander A: Olanzapine in schizphrenia refractory to typical and atypical antipsychotics: An opne lable, prospective trial. American Psychiatric Annual Meeting May 1999, New Research Poster Lindenmayer et al. (unpublished\/personal communication) OMH Pharmacy and Therapeutics subcommittee on Algorithm for treatment refractory schizophrenia, 1999."},{"key":"226391_CR21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1176\/ajp.152.1.153","volume":"152","author":"HY Meltzer","year":"1995","unstructured":"Meltzer HY, Okayli G: Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment. Am J Psychiatry 152:183\u2013190, 1995.","journal-title":"Am J Psychiatry"},{"key":"226391_CR22","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/archpsyc.1984.01790160098013","volume":"41","author":"HY Meltzer","year":"1984","unstructured":"Meltzer HY et al.: Growth hormone and prolactin response to apomorphine in schizophrenia and the major affective disorders. Arch Gen Psychiatry 41:512\u2013519 1984.","journal-title":"Arch Gen Psychiatry"},{"key":"226391_CR23","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1056\/NEJM199709183371202","volume":"337","author":"R Rosenheck","year":"1997","unstructured":"Rosenheck R, Cramer J, Xu W, et al.: A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. N Engl J Med 337:809\u2013815, 1997.","journal-title":"N Engl J Med"},{"key":"226391_CR24","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1176\/ajp.139.8.991","volume":"139","author":"DP van Kammen","year":"1982","unstructured":"van Kammen DP et al.: d-Amphetamine-induced heterogeneous changes in psychotic behavior in schizophrenia. Am J Psychiatry 139:991\u2013997, 1982.","journal-title":"Am J Psychiatry"},{"key":"226391_CR25","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1176\/ajp.156.7.990","volume":"156","author":"K Wahlbeck","year":"1999","unstructured":"Wahlbeck K, Cheine M, Essali A, and Adams C: Evidence of clozapine's effectiveness in schizophrenia: A systematic review and meta-analysis of randomized trials. Am J of Psychiatry 156:990\u2013999, 1999.","journal-title":"Am J of Psychiatry"},{"key":"226391_CR26","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/archpsyc.1980.01780140013001","volume":"37","author":"DR Weinberger","year":"1980","unstructured":"Weinberger DR, Bigelow LB, Kleinman JE, Klein ST, Rosenblatt JE, Wyatt RJ: Cerebral ventricular enlargement in chronic schizophrenia: an association with poor response to treatment. Arch Gen Psychiatry 37:11\u201313, 1980.","journal-title":"Arch Gen Psychiatry"},{"key":"226391_CR27","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1176\/ajp.156.9.1374","volume":"156","author":"D Wirshing","year":"1999","unstructured":"Wirshing D, Marshall B, Green M, Mintz J, Marder S Wirshing W: Risperidone in treatment-refractory schizophrenia. Am J Psych 156:1374\u20131379, 1999.","journal-title":"Am J Psych"},{"key":"226391_CR28","unstructured":"Wolkin A: PET in the study of neuroleptic response, in The Neuroleptic-Nonresponsive Patient: Characterization and Treatment (Angrist &; Schulz, eds.) Am Psychiatric Press Inc. 1990."}],"container-title":["Psychiatric Quarterly"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1004640408501.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1004640408501\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1004640408501.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T12:40:25Z","timestamp":1754397625000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1004640408501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,12]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,12]]}},"alternative-id":["226391"],"URL":"https:\/\/doi.org\/10.1023\/a:1004640408501","relation":{},"ISSN":["0033-2720","1573-6709"],"issn-type":[{"value":"0033-2720","type":"print"},{"value":"1573-6709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,12]]}}}